List of bibliographic references indexed by Vaccins antiviraux
Number of relevant bibliographic references: 293.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000044 (2020) |
Rong-Sheng Luan [République populaire de Chine] ; Xin Wang [République populaire de Chine] ; Xin Sun [République populaire de Chine] ; Xing-Shu Chen [République populaire de Chine] ; Tao Zhou [République populaire de Chine] ; Quan-Hui Liu [République populaire de Chine] ; Xin Lü [République populaire de Chine] ; Xian-Ping Wu [République populaire de Chine] ; Dong-Qing Gu [République populaire de Chine] ; Ming-Shuang Tang [République populaire de Chine] ; Hui-Jie Cui [République populaire de Chine] ; Xue-Feng Shan [République populaire de Chine] ; Jing Ouyang [République populaire de Chine] ; Ben Zhang [République populaire de Chine] ; Wei Zhang [République populaire de Chine] ; Emergency Research Group Sichuan University Covid- [République populaire de Chine] | [Epidemiology, Treatment, and Epidemic Prevention and Control of the Coronavirus Disease 2019: a Review]. |
| 000050 (2020) |
Cai-Xia Yan [République populaire de Chine] ; Jia Li [République populaire de Chine] ; Xin Shen [République populaire de Chine] ; Li Luo [République populaire de Chine] ; Yan Li [République populaire de Chine] ; Ming-Yuan Li [République populaire de Chine] | [Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019]. |
| 000051 (2020) |
Susannah Leach | [At least 68 vaccine candidates under development]. |
| 000078 (2020) |
Yuefei Jin [République populaire de Chine] ; Haiyan Yang [République populaire de Chine] ; Wangquan Ji [République populaire de Chine] ; Weidong Wu [République populaire de Chine] ; Shuaiyin Chen [République populaire de Chine] ; Weiguo Zhang [République populaire de Chine] ; Guangcai Duan [République populaire de Chine] | Virology, Epidemiology, Pathogenesis, and Control of COVID-19. |
| 000103 (2020) |
Shan Lu | Timely development of vaccines against SARS-CoV-2 |
| 000126 (2020) |
Carlo Contini [Italie] ; Mariachiara Di Nuzzo [Italie] ; Nicole Barp [Italie] ; Aurora Bonazza [Italie] ; Roberto De Giorgio [Italie] ; Mauro Tognon [Italie] ; Salvatore Rubino [Italie] | The novel zoonotic COVID-19 pandemic: An expected global health concern. |
| 000222 (2020) |
Kun Li [États-Unis] ; Zhuo Li [États-Unis] ; Christine Wohlford-Lenane [États-Unis] ; David K. Meyerholz [États-Unis] ; Rudragouda Channappanavar [États-Unis] ; Dong An [États-Unis] ; Stanley Perlman [États-Unis] ; Paul B. Mccray [États-Unis] ; Biao He [États-Unis] | Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection |
| 000376 (2020) |
Syed Faraz Ahmed ; Ahmed A. Quadeer ; Matthew R. Mckay [République populaire de Chine] | Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies |
| 000391 (2020) |
Lei Zhang [République populaire de Chine] ; Yunhui Liu [République populaire de Chine] | Potential interventions for novel coronavirus in China: A systematic review. |
| 000398 (2020) |
David A. Schwartz [États-Unis] ; Ashley L. Graham | Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections |
| 000567 (2020) |
Eakachai Prompetchara [Thaïlande] ; Chutitorn Ketloy [Thaïlande] ; Tanapat Palaga [Thaïlande] | Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. |
| 000602 (2020) |
Hanako Sekimukai [Japon] ; Naoko Iwata-Yoshikawa [Japon] ; Shuetsu Fukushi [Japon] ; Hideki Tani [Japon] ; Michiyo Kataoka [Japon] ; Tadaki Suzuki [Japon] ; Hideki Hasegawa [Japon] ; Kenichi Niikura [Japon] ; Katsuhiko Arai [Japon] ; Noriyo Nagata [Japon] | Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs. |
| 000713 (2020) |
Shibo Jiang | Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees. |
| 000746 (2020) |
Dae-Gyun Ahn [Corée du Sud] ; Hye-Jin Shin [Corée du Sud] ; Mi-Hwa Kim [Corée du Sud] ; Sunhee Lee [Corée du Sud] ; Hae-Soo Kim [Corée du Sud] ; Jinjong Myoung [Corée du Sud] ; Bum-Tae Kim [Corée du Sud] ; Seong-Jun Kim [Corée du Sud] | Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19). |
| 000795 (2020) |
B. Robson [États-Unis, Royaume-Uni] | Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus |
| 000979 (2020) |
Ahmad Alimadadi [États-Unis] ; Sachin Aryal [États-Unis] ; Ishan Manandhar [États-Unis] ; Patricia B. Munroe [États-Unis] ; Bina Joe [États-Unis] ; Xi Cheng [États-Unis] | Artificial intelligence and machine learning to fight COVID-19. |
| 000A45 (2020) |
Yung-Fang Tu [Taïwan] ; Chian-Shiu Chien [Taïwan] ; Aliaksandr A. Yarmishyn [Taïwan] ; Yi-Ying Lin [Taïwan] ; Yung-Hung Luo [Taïwan] ; Yi-Tsung Lin [Taïwan] ; Wei-Yi Lai [Taïwan] ; De-Ming Yang [Taïwan] ; Shih-Jie Chou [Taïwan] ; Yi-Ping Yang [Taïwan] ; Mong-Lien Wang [Taïwan] ; Shih-Hwa Chiou [Taïwan] | A Review of SARS-CoV-2 and the Ongoing Clinical Trials. |
| 000A55 (2020) |
Chloe Hyun-Jung Lee [Royaume-Uni] ; Hashem Koohy [Royaume-Uni] | In silico identification of vaccine targets for 2019-nCoV |
| 000A60 (2020) |
Robyn Ralph [Canada] ; Jocelyne Lew [Canada] ; Tiansheng Zeng [République populaire de Chine] ; Magie Francis [Canada] ; Bei Xue [République populaire de Chine] ; Melissa Roux [Canada] ; Ali Toloue Ostadgavahi [Canada] ; Salvatore Rubino [Italie] ; Nicholas J. Dawe [Canada] ; Mohammed N. Al-Ahdal [Arabie saoudite] ; David J. Kelvin [République populaire de Chine] ; Christopher D. Richardson [Canada] ; Jason Kindrachuk [Canada] ; Darryl Falzarano [Canada] ; Alyson Anne Kelvin [Canada] | 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness. |
| 000B39 (2019) |
Zhiqi Song [République populaire de Chine] ; Yanfeng Xu [République populaire de Chine] ; Linlin Bao [République populaire de Chine] ; Ling Zhang [République populaire de Chine] ; Pin Yu [République populaire de Chine] ; Yajin Qu [République populaire de Chine] ; Hua Zhu [République populaire de Chine] ; Wenjie Zhao [République populaire de Chine] ; Yunlin Han [République populaire de Chine] ; Chuan Qin [République populaire de Chine] | From SARS to MERS, Thrusting Coronaviruses into the Spotlight |
| 000C08 (2018) |
Sara Reardon | US government lifts ban on risky pathogen research. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Vaccins antiviraux"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i \
-Sk "Vaccins antiviraux" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= MeshFr.i
|clé= Vaccins antiviraux
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021 |  |
